These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


710 related items for PubMed ID: 15299044

  • 21. Pharmacologic stabilization of hypoxia-inducible transcription factors protects developing mouse brain from hypoxia-induced apoptotic cell death.
    Trollmann R, Richter M, Jung S, Walkinshaw G, Brackmann F.
    Neuroscience; 2014 Oct 10; 278():327-42. PubMed ID: 25162122
    [Abstract] [Full Text] [Related]

  • 22. Hematopoietic progenitor cell mobilization results in hypoxia with increased hypoxia-inducible transcription factor-1 alpha and vascular endothelial growth factor A in bone marrow.
    Lévesque JP, Winkler IG, Hendy J, Williams B, Helwani F, Barbier V, Nowlan B, Nilsson SK.
    Stem Cells; 2007 Aug 10; 25(8):1954-65. PubMed ID: 17478585
    [Abstract] [Full Text] [Related]

  • 23. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
    Knowles HJ, Athanasou NA.
    J Pathol; 2008 May 10; 215(1):56-66. PubMed ID: 18283716
    [Abstract] [Full Text] [Related]

  • 24. Use of gene-manipulated mice in the study of erythropoietin gene expression.
    Suzuki N, Obara N, Yamamoto M.
    Methods Enzymol; 2007 May 10; 435():157-77. PubMed ID: 17998054
    [Abstract] [Full Text] [Related]

  • 25. Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma.
    Jiang CQ, Fan LF, Liu ZS, Qian Q, Xia D, Diao LM, He YM, Ai ZL.
    Chin Med J (Engl); 2004 Oct 10; 117(10):1541-6. PubMed ID: 15498380
    [Abstract] [Full Text] [Related]

  • 26. Ginkgolides mimic the effects of hypoxic preconditioning to protect C6 cells against ischemic injury by up-regulation of hypoxia-inducible factor-1 alpha and erythropoietin.
    He W, Qian Zhong M, Zhu L, Christopher Q, Du F, Yung WH, Ke Y.
    Int J Biochem Cell Biol; 2008 Oct 10; 40(4):651-62. PubMed ID: 18054269
    [Abstract] [Full Text] [Related]

  • 27. The erythropoietin receptor and its expression in tumor cells and other tissues.
    Farrell F, Lee A.
    Oncologist; 2004 Oct 10; 9 Suppl 5():18-30. PubMed ID: 15591419
    [Abstract] [Full Text] [Related]

  • 28. Activation of hypoxia-inducible factor-1 in bacillary angiomatosis: evidence for a role of hypoxia-inducible factor-1 in bacterial infections.
    Kempf VA, Lebiedziejewski M, Alitalo K, Wälzlein JH, Ehehalt U, Fiebig J, Huber S, Schütt B, Sander CA, Müller S, Grassl G, Yazdi AS, Brehm B, Autenrieth IB.
    Circulation; 2005 Mar 01; 111(8):1054-62. PubMed ID: 15723970
    [Abstract] [Full Text] [Related]

  • 29. Anemia and cerebral outcomes: many questions, fewer answers.
    Hare GM, Tsui AK, McLaren AT, Ragoonanan TE, Yu J, Mazer CD.
    Anesth Analg; 2008 Oct 01; 107(4):1356-70. PubMed ID: 18806052
    [Abstract] [Full Text] [Related]

  • 30. A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma.
    Das B, Yeger H, Tsuchida R, Torkin R, Gee MF, Thorner PS, Shibuya M, Malkin D, Baruchel S.
    Cancer Res; 2005 Aug 15; 65(16):7267-75. PubMed ID: 16103078
    [Abstract] [Full Text] [Related]

  • 31. Autocrine function of erythropoietin in IGF-1-induced erythropoietin biosynthesis.
    Kim I, Kim CH, Yim YS, Ahn YS.
    Neuroreport; 2008 Nov 19; 19(17):1699-703. PubMed ID: 18841090
    [Abstract] [Full Text] [Related]

  • 32. Expression of erythropoietin and angiogenic growth factors following inner ear injury of newborn rats.
    Gross J, Moller R, Amarjargal N, Machulik A, Fuchs J, Ungethüm U, Kuban RJ, Henke W, Haupt H, Mazurek B.
    Prague Med Rep; 2009 Nov 19; 110(4):310-31. PubMed ID: 20059883
    [Abstract] [Full Text] [Related]

  • 33. High glucose blunts vascular endothelial growth factor response to hypoxia via the oxidative stress-regulated hypoxia-inducible factor/hypoxia-responsible element pathway.
    Katavetin P, Miyata T, Inagi R, Tanaka T, Sassa R, Ingelfinger JR, Fujita T, Nangaku M.
    J Am Soc Nephrol; 2006 May 19; 17(5):1405-13. PubMed ID: 16597689
    [Abstract] [Full Text] [Related]

  • 34. Upregulation of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha in leptomeningeal vascular malformations of Sturge-Weber syndrome.
    Comati A, Beck H, Halliday W, Snipes GJ, Plate KH, Acker T.
    J Neuropathol Exp Neurol; 2007 Jan 19; 66(1):86-97. PubMed ID: 17204940
    [Abstract] [Full Text] [Related]

  • 35. Experimental evidence of the potential use of erythropoietin by intranasal administration as a neuroprotective agent in cerebral hypoxia.
    Merelli A, Caltana L, Lazarowski A, Brusco A.
    Drug Metabol Drug Interact; 2011 Jan 19; 26(2):65-9. PubMed ID: 21756166
    [Abstract] [Full Text] [Related]

  • 36. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
    Simiantonaki N, Jayasinghe C, Michel-Schmidt R, Peters K, Hermanns MI, Kirkpatrick CJ.
    Int J Oncol; 2008 Mar 19; 32(3):585-92. PubMed ID: 18292935
    [Abstract] [Full Text] [Related]

  • 37. Erythropoietin disrupts hypoxia-inducible factor signaling in ovarian cancer cells.
    Hale SA, Wong C, Lounsbury KM.
    Gynecol Oncol; 2006 Jan 19; 100(1):14-9. PubMed ID: 16226302
    [Abstract] [Full Text] [Related]

  • 38. Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis.
    Distler O, Distler JH, Scheid A, Acker T, Hirth A, Rethage J, Michel BA, Gay RE, Müller-Ladner U, Matucci-Cerinic M, Plate KH, Gassmann M, Gay S.
    Circ Res; 2004 Jul 09; 95(1):109-16. PubMed ID: 15178641
    [Abstract] [Full Text] [Related]

  • 39. [Function, molecular structure and gene expression regulation of erythropoietin].
    Miyazaki H.
    Nihon Rinsho; 1992 Aug 09; 50(8):1879-84. PubMed ID: 1433979
    [Abstract] [Full Text] [Related]

  • 40. Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agents.
    Tanaka T, Nangaku M.
    Exp Cell Res; 2012 May 15; 318(9):1068-73. PubMed ID: 22414872
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 36.